Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its
Eriko Abe1,2, Akio Yamashita3, Keigo Hirota1
1Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Abstract:
Kidney fibrosis is a common pathway that leads to chronic kidney disease. Angiotensin II type-1 receptor (AT1R)-associated protein (ATRAP) was originally identified as an AT1R-binding protein. Previously, we reported that systemic knockout of ATRAP exacerbates kidney fibrosis in aged mice. Although these effects of ATRAP appeared to be AT1R-independent actions, the molecular mechanism remains poorly understood. To elucidate the molecular mechanism of ATRAP independent of AT1R, we explored novel ATRAP-interacting proteins. Mass spectrometric analysis of the immunoprecipitants of a Flag-tagged ATRAP complex revealed 376 candidate proteins that potentially interact with ATRAP. Gene ontology analysis revealed that proteins related to vesicle trafficking, membrane transport, and many membrane proteins, including transferrin receptor 1 (TfR1), were enriched. Because TfR1 promotes cellular iron uptake and iron is a key factor involved in kidney fibrosis, we focused on TfR1 and confirmed that it interacts with ATRAP. In addition, our findings revealed that enhanced ATRAP expression decreased cell-surface TfR1 expression without altering the overall cellular TfR1 expression levels. Furthermore, enhanced ATRAP expression attenuated cellular iron levels. Together, our results highlight the role of ATRAP as a suppressor of TfR1 that functions by facilitating TfR1 internalization, which affects iron metabolism and oxidative stress signaling.
Insights
Angiotensin II type-1 receptor-associated protein (ATRAP) suppresses kidney fibrosis by reducing cell-surface transferrin receptor 1 (TfR1). This action impacts iron metabolism and oxidative stress, offering new therapeutic targets for chronic kidney disease.
Area of Science:
- Nephrology
- Molecular Biology
- Biochemistry
Background:
- Kidney fibrosis is a central mechanism in chronic kidney disease progression.
- Angiotensin II type-1 receptor-associated protein (ATRAP) has been implicated in kidney fibrosis, with previous studies suggesting AT1R-independent actions.
- The precise molecular mechanisms underlying ATRAP's role in kidney fibrosis remain unclear.
Purpose of the Study:
- To elucidate the AT1R-independent molecular mechanisms of ATRAP in kidney fibrosis.
- To identify novel ATRAP-interacting proteins.
- To investigate the functional relationship between ATRAP and transferrin receptor 1 (TfR1) in the context of kidney fibrosis.
Main Methods:
- Mass spectrometry-based proteomics to identify ATRAP-interacting proteins.
- Immunoprecipitation and Western blotting to confirm protein-protein interactions.
- Cell-based assays to assess cell-surface protein expression, cellular iron levels, and oxidative stress signaling.
Main Results:
- Proteomic analysis identified 376 candidate ATRAP-interacting proteins, enriched for functions in vesicle trafficking and membrane transport.
- Transferrin receptor 1 (TfR1), a key regulator of cellular iron uptake, was identified as an ATRAP interactor.
- Enhanced ATRAP expression led to decreased cell-surface TfR1 levels, reduced cellular iron uptake, and attenuated oxidative stress signaling, independent of overall TfR1 expression.
Conclusions:
- ATRAP acts as a suppressor of TfR1 by promoting its internalization.
- This ATRAP-TfR1 interaction influences cellular iron metabolism and oxidative stress pathways relevant to kidney fibrosis.
- Targeting the ATRAP-TfR1 axis presents a potential therapeutic strategy for mitigating kidney fibrosis.
Related Concept Videos
The Early Endosome: Endocytosis of Transferrin
Receptor-mediated Endocytosis
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Tail-anchoring of Proteins in the ER Membrane
Internal Receptors
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...


